Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline vs Nicotine Patch for Smoking Cessation in Coronary Heart Disease
NCT00959972Phase 4Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Apr 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by University of Ottawa Heart Institute. Primary endpoint: Continuous Abstinence Rate at 12 weeks. Started Apr 2009; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00959972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959972.